Diabetes - Perspectives in Drug Therapy: Handbook of Experimental Pharmacology, cartea 203
Editat de Mathias Schwanstecheren Limba Engleză Paperback – 21 apr 2013
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 2785.32 lei 43-57 zile | |
Springer Berlin, Heidelberg – 21 apr 2013 | 2785.32 lei 43-57 zile | |
Hardback (1) | 2790.50 lei 43-57 zile | |
Springer Berlin, Heidelberg – 14 mar 2011 | 2790.50 lei 43-57 zile |
Din seria Handbook of Experimental Pharmacology
- 5% Preț: 1425.01 lei
- 5% Preț: 907.40 lei
- 5% Preț: 3416.51 lei
- 5% Preț: 730.29 lei
- 5% Preț: 1385.01 lei
- 5% Preț: 1394.05 lei
- 5% Preț: 1389.42 lei
- 5% Preț: 1875.16 lei
- 5% Preț: 1867.18 lei
- 5% Preț: 1881.75 lei
- 5% Preț: 2056.67 lei
- 5% Preț: 2058.97 lei
- 5% Preț: 2056.47 lei
- 5% Preț: 1088.13 lei
- 5% Preț: 1066.75 lei
- 5% Preț: 1379.49 lei
- 5% Preț: 1073.13 lei
- 5% Preț: 1073.13 lei
- 5% Preț: 1076.34 lei
- 5% Preț: 1074.94 lei
- 5% Preț: 1074.03 lei
- 5% Preț: 1140.64 lei
- 5% Preț: 396.86 lei
- 5% Preț: 397.94 lei
- 5% Preț: 539.89 lei
- 5% Preț: 699.85 lei
- 5% Preț: 712.10 lei
- 5% Preț: 710.33 lei
- 5% Preț: 725.06 lei
- 5% Preț: 726.31 lei
- 5% Preț: 704.46 lei
- 5% Preț: 721.53 lei
- 5% Preț: 382.03 lei
- 5% Preț: 714.59 lei
- 5% Preț: 707.47 lei
- 5% Preț: 378.40 lei
- 5% Preț: 709.79 lei
- 5% Preț: 719.37 lei
- 5% Preț: 709.28 lei
- 5% Preț: 702.70 lei
- 5% Preț: 710.33 lei
- 5% Preț: 705.86 lei
- 5% Preț: 3415.25 lei
- 5% Preț: 708.37 lei
- 5% Preț: 716.01 lei
- 5% Preț: 709.98 lei
- 5% Preț: 717.61 lei
- 5% Preț: 883.86 lei
- 5% Preț: 699.49 lei
Preț: 2785.32 lei
Preț vechi: 2931.93 lei
-5% Nou
Puncte Express: 4178
Preț estimativ în valută:
533.11€ • 555.63$ • 443.79£
533.11€ • 555.63$ • 443.79£
Carte tipărită la comandă
Livrare economică 06-20 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642267420
ISBN-10: 3642267424
Pagini: 424
Ilustrații: XIII, 408 p. 69 illus.
Dimensiuni: 155 x 235 x 22 mm
Greutate: 0.59 kg
Ediția:2011
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Handbook of Experimental Pharmacology
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642267424
Pagini: 424
Ilustrații: XIII, 408 p. 69 illus.
Dimensiuni: 155 x 235 x 22 mm
Greutate: 0.59 kg
Ediția:2011
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Handbook of Experimental Pharmacology
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
Preface. Targeting type 2 diabetes. Dual acting and pan-PPAR activators as potential anti-diabetic therapies. GLP-agonists and Dipeptidyl-Peptidase IV Inhibitors. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. SGLT Inhibitors as New Therapeutic Tools in the Treatment of Diabetes. Inhibitors of 11b-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy. Nampt and its potential role in inflammation and type 2 diabetes. Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance. Overcoming Insulin Resistance with Ciliary Neurotrophic Factor. Thermogenesis and related metabolic targets in anti-diabetic therapy. Interleukin targeted therapy for metabolic syndrome and type 2 diabetes. Fructose-1, 6-Bisphosphatase Inhibitors for Reducing Excessive Endogenous Glucose Production in Type 2 Diabetes. AMP-activated protein kinase and metabolic control. Mitochondria as potential targets in antidiabetic therapy. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects
Textul de pe ultima copertă
Every 5 seconds someone somewhere is diagnosed with diabetes, and every 10 seconds someone dies of it. Even worse, worldwide incidence rates still inexorably escalate. Thus, it is pressing to envisage the extent of the diabetes problem and ensure synergistic approaches aiming in alleviation of its ghastly toll.The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.
Caracteristici
Features excellent reviews of international experts on cutting edge diabetes research Provides a detailed up to date overview of cellular and molecular mechanisms involved in obesity driven development of type 2 diabetes Focuses on potential novel drug targets, thus opening the way for innovative strategies in diabetes and obesity therapy Includes supplementary material: sn.pub/extras